Jaime L. Schneider, M.D., Ph.D., is an attending physician in the Center for Thoracic Cancers at the Massachusetts General Hospital. She is an instructor in Medicine at Harvard Medical School. 

Dr. Schneider earned her bachelor’s degree in Biology at Northwestern University and her M.D. and Ph.D. degrees from the Albert Einstein College of Medicine. She completed her internship and residency in internal medicine at Massachusetts General Hospital as part of the MGH Stanbury Physician-Scientist Program. She subsequently trained in the Dana-Farber/MGH/Harvard joint hematology/oncology fellowship program.

Dr. Schneider cares for patients with lung cancer and other thoracic malignancies, and additionally performs basic and translational research. Dr. Schneider’s major research interests include studying driver oncogene alterations in non-small cell lung cancer and the development of resistance to targeted therapies. She is using integrative metabolomics approaches to identify resistance mechanisms and understand how metabolic reprogramming underlies resistance to targeted therapies. 

Her work has been recognized by awards and grants from organizations such as A Breath of Hope Lung Foundation, EGFR Resisters, and IASLC Targeted Therapy of Lung Cancer. As a physician-scientist, Dr. Schneider is passionate about treating patients with lung cancer and is committed to developing novel therapeutic approaches using innovative scientific tools.